Чтение онлайн

SARS. 2003. Сайт ВОЗ. http://www.who.int/niediacentre/releas/2003/pr31/en/print.htm

35. Deffransnesss C, Cote S., Boivin G., Analysis of replication of the human metapneumovirus

Lacking the smal hydrophobic SH and/or attachment G glycoprotein, deletion of G yields a

promising vaccine candidates. // J. Virol. 2004; 78; 12877-87.

36. Durbin J., Jonson T., Durbin R.K. et al. The role of IFN in RSV pathogenesis. // J. of Immunologists - 2002 - p. 2944 - 2952.

37. Fleming J.O., Trousdale M.D. et al. Pathogenicity of antigenic variants of murine coronavirus

JNM selected with monoclonal antibodies. // J. Virol.
– 1986.
– Vol. 58, N.3 - p. 869-875.

38. Foucher R.A.M., Munster V., Wallenste A. et al. Characterization of novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. // S. of Virology - 2005 - V.79 - N5 - p. 2814 - 22.

39. Foulongne V, Oleinic Y, Perez V, Elaerts S, Rodiere M, Segondy M. Human Bocavirus in

French children. //Emerg. Infect. Dis.
– 2006.
– v.15.
– 8.
– p.1251-1253.

40. Gorbach N., Bartleett S., Blacklow J. Infection Diseases.
– Philadelphia: W.B. Saunders Company - 1998.

41. Gottschalk J., Zbinden R., Kaempf L. et al. Discrimination of Respiratory Syncytial Virus subgroup A and B by Reverse Transcription - PCR. // J. Clin. Microbiol - 1996 - p. 41 - 43.

42. Hamelin M.E., Abed Y., Boivin G. Human metapneumovirus: a new player among respiratory viruses. // Clinical Infect Dis - 2004.

43. Hayden F. WHO Guidelines in the Use of vaccines and Antivirals during influenza pandemic - Geneva - - 2002.

44 . Hierhoizer J.C. Adenoviruses in the immunocompromised host. Clin. Microbiol. Rev. 5: 1992. p. 262-274.

45. Но Т., Couceiro J.C., Kelm S. et al. Molecular basis for the generation in pigs of influenza A

viruses with pandemic potential. // Ibid.
– 1998.
– Vol. 72.
– p. 7367-73.

46. Horimoto Т., Fukuda N., Iwatsuki-Horimoto R. et al (2004). Antigenic differences between

H5N1 viruses isolated from humans in 1997 and 2003. Journal of Veterinary Medical Science

(Tokyo) 66, 303-5.

47. Imaz M., Sequera M., Videla С. et al. Clinical and epidemiologic characteristic of Respiratory

Syncytial Virus subgroup A and В infections in Santa Fe, Argentina. // J. of Med. Vir.
– 2000.

– N61.-p. 76-80.

48. Immune response, Immunopathogenesis and treatment. // Clin. Microbiol. Rev.
– 1999.
– Apr.

– p. 298-309.

49. Influenza. // Weekly Epidemiol. Rec.
– 2001.
– N9.
– V. 76.
– p.85.

50 . Influenza // Weekly Epidemiol. Rec.
– 2004 - N 32 - V. 72 - P. 291 - 292.

51. Kawaoka Y., Krauss S., Webster R.G. Avian-tj-human transmission of the PB1 gene of influenza A virus in the 1957 and 1968 pandemics. // J/ Virol - 1989 - V. 63 - p. 4603 - 4608.

52. Kelsey D.S. Adenovirus meningoencephalits. Pediatric. 6/: 291-293 (1978).

53. Klenk H.D., Rott R., Orlich M., Blodorn J. Activation of influenza A viruses by trispin treatment.// Virology - 1975 - V.68 - p. 426 - 39.

54. Knossow M., Daniels R.S., et al. Three-dimensional structure of antigenic mutant of the influenza virus haemagglutinin. // Nature - 1984 - V.311 - p. 678- - 80.

55. Koopmans M., Wilbrink B., Conyn M. et al. Transmission of H7N7 avian influenza A virus to human beinds during a large outbreak in commercial poultry farms in the Netherlans/ Lancet - 2004.

56. Kuypers J., Wright N., Corey L., Morrow R. Detection and quantification of human

metapneumovirus in pediatric specimens by real-time RT-PCR. // J. Clin. Virol. 2005; 33;

290-305.

57. Lipsitch M., Cohen Т., Cooper B. et al. Trasmission dynamics and control of severe acute

respiratory syndrome. Science 300: 1966-1970, 2003. Medline/Similar articles/Full articles.

58. Ma X., Endo R., Ishiguro N., Ebihara T._? Ishiko H., Ariga T. et al. Detection of human Bocavirus in Japanese children with lower respiratory tract infections.//J.Clin_? Microbiol.
–

2006.
– v.44.-p.l 132-1134.

59. Martin L.D., Rochell L.G., Fisher B.M. et al. Airway epithelium as an effector of inflammation. // Eur. Respir. J. 1997. Vol. 10 p. 2139-2146.

60. Oxford J.S., Hockley D.J. Orthomyxoviridae. // Animal virus structure - 1987 - p. 213 - 232.

61. Palase P., Shulman J.L. Mapping of influenza virus genom: identification of the hemagglutinin and neuraminidase genes.// PNAS USA - 1976 - V.73 - p. 2142 - 46.

62. Polack F., Teng M., Collins P. et al. A role for for immune complex in enhanced PSV disease. // J. of Experim. Med - 2002 - p. 859 - 865.

63. Riley S., Fraser C, Donnelly C.A. et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public heath interventions. Scince 300: 1961-1966, 2003. Medline - Similar articles - Full articles.

64. Schildren O., Geikowski Т., Glatzel T. et al. New variant of the human metapneumovirus

associated with in an acute and severe exacerbation of asthma bronchiole. // J. Clin. Virol.

2004. p. 1-6.

65. Schildren O., Glatzel T. Geikowski Т., et al. Human metapneumovirus RNA in encephalitis

patient. Emerging Infee. Dis. www.cdc.gov/eid. Vol. 11 N3, March 2005.

66. Semple A.B. Epidemiology of the influenza epidemic in Liverpool in 1950-1951. // Proc. R. Soc. Med - 1951 - V.44 - p. 794 - 796.

67. Simila S., Ylikorkala O., and Wasz-Hockert O. Type 7 adenovirus pneumonia. J. Pediatr. 79: p. 605-611(1971).

68. Simonsen L., Clarke M.J., Williamson J.D., et al. The impact of influenza epidemics on morality, introducing a severity index // Ann. J. Public Health - 1967 - V. 87 - P. 1944 - 1950.

69. Skiadopoulos M.H., Biacchesi S. Buchholz U. et al. The two major human metapneumovirus

genetic lineages are highly related antigenically, and the fusion (F) protein is a major